Microanalysis of packaging ink points to problem in manufacturing process

Pharmaceutical company discovers discoloration problem through microanalysis.

McCrone blue substance
McCrone blue substance

Pharmaceutical packaging is designed to keep the product free from damage and contamination; however, occasionally the packaging itself is the source of product contamination. A pharmaceutical company noticed a problem with several white tablets that displayed small blue defects at random locations on all faces of the tablets. The defects were less than 0.1mm in size, as shown in the photograph here.

When the tablets were cross-sectioned with a razor blade, it was found that the defects were limited to the outer surface of the tablets, and consisted of very thin flakes of a blue substance. The pharmaceutical firm suspected that the defects were fiber fragments from blue cloth wipes or blue hairnets that were used in the process areas of the manufacturing plant. While working in a cleanroom under a stereomicroscope, McCrone removed some of the blue flakes from the tablets by hand by with the aid of fine tungsten needles.

Need help with your packaging project?
We’ve done the legwork to identify and vet experienced packaging and processing consultants you can contact directly for your next project. Decades of combined experience in packaging line engineering, machinery selection, package and materials development, and food processing operations.
See your advisor options now.
Need help with your packaging project?
Don't miss Packaging Recycling Summit 2026
Where innovation meets sustainability. Join the leading forum for packaging recycling professionals, featuring cutting-edge solutions, expert insights, and the connections you need to advance the circular economy. Secure your spot today.
Discover More
Don't miss Packaging Recycling Summit 2026